Return to homepagePandemic Pact

AP-HP-CoviCompare-m: refining knowledge of the immune responses of people aged 65 and over vaccinated with Moderna

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    Inserm

  • Principal Investigator

    N/A

  • Research Location

    France

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)Older adults (65 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

In concrete terms, the trial envisages the creation of three groups of 60 participants: The first whose participants are between 18 and 45 years of age The second whose participants are between 65 and 74 years of age And the third whose participants are aged 75 and over The volunteers will each receive two injections of the vaccine, 28 days apart.